TRA-COAT
The TRA-COAT project combats implant infections with a novel coating, featuring antibiofilm activity and triggered antimicrobial release. It focuses on orthopaedic and vascular implants, enhancing durability and reducing resistance development.
The TRA-COAT coating offers multiple advantages:
1. Antibiofilm Activity: Prevents biofilm formation, reducing infection risk.
2. Triggered Antimicrobial Release: Activates only when bacterial growth is detected.
3. Resistance-Proof: Biofilm inhibitors are robust against resistance.
4. Versatile Application: Initially for orthopedic and vascular implants, extendable to other devices.
5. Better Patient Outcomes: Decreases infection rates and antimicrobial resistance.
Technology:
Microorganisms:
Application:
Development stage:
- Infection prevention
- Antimicrobial compound/strategy
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Academia
- Company
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- BSI
- SSI
- UTI
- STI
- RTI
- GII
- SSTI
- CNSI
- IAI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
N.A.
University
NA
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!